Anterix Inc. (ATEX) awards 1,598 common shares to board director

Rhea-AI Filing Summary

Fleischhauer Mark reported acquisition or exercise transactions in this Form 4 filing.

Anterix Inc. director Mark Fleischhauer received a grant of 1,598 shares of common stock as a stock award. The shares vest on the earlier of the company’s 2027 Annual Meeting of shareholders and August 4, 2027, under a Restricted Stock Agreement, bringing his direct holdings to 14,367 shares.

Insider Trade Summary

Net Buyer: 1,598 shares

Net Buy 1 txn

Insider Fleischhauer Mark

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	1,598	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,367 shares (Direct)

Footnotes (1)

1. F1. The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.

Key Figures

Shares granted: 1,598 shares Award price: $0.0000 per share Director holdings after grant: 14,367 shares +1 more

4 metrics

Shares granted 1,598 shares Equity award of common stock to director on 2026-08-04

Award price $0.0000 per share Reported transaction price for granted common stock

Director holdings after grant 14,367 shares Total common stock beneficially owned directly after the award

Vesting date August 4, 2027 Shares vest on earlier of 2027 Annual Meeting of shareholders and this date

Key Terms

Restricted Stock Agreement, Annual Meeting of shareholders, Grant, award, or other acquisition

3 terms

Restricted Stock Agreement financial

"subject to the terms of the Restricted Stock Agreement"

Annual Meeting of shareholders regulatory

"vest on the earlier of the 2027 Annual Meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 10:16 AM Accepted by SEC EDGAR 08/06/2026 - 10:16 AM Learn about SEC filing dates

FAQ

What insider transaction did Anterix (ATEX) report for Mark Fleischhauer?

Anterix reported that director Mark Fleischhauer received an equity grant of 1,598 shares of common stock. This award increased his direct holdings to 14,367 shares, reflecting additional stock-based compensation rather than an open-market purchase.

How many Anterix (ATEX) shares were granted to the director and at what price?

The director was granted 1,598 shares of Anterix common stock at a reported transaction price of $0.0000 per share. This indicates a compensatory stock award, not a cash purchase, consistent with typical director equity compensation structures.

When do the newly granted Anterix (ATEX) shares vest for Mark Fleischhauer?

The 1,598 granted shares vest on the earlier of Anterix’s 2027 Annual Meeting of shareholders and August 4, 2027. Vesting remains subject to the terms and conditions of the applicable Restricted Stock Agreement governing this equity award.

What is Mark Fleischhauer’s total Anterix (ATEX) share ownership after this grant?

Following the award, Mark Fleischhauer directly beneficially owns 14,367 shares of Anterix common stock. This total includes the newly granted 1,598 shares subject to vesting, as reported in the insider ownership figures after the transaction.

Was the Anterix (ATEX) stock grant to Mark Fleischhauer under a Rule 10b5-1 plan?

The report indicates the Rule 10b5-1 trading plan checkbox was not marked, so the grant was not affirmed as made under a Rule 10b5-1 plan. It appears as a standard director equity compensation grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fleischhauer Mark

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NEW JERSEY 07424

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		A		1,598(1)	A	$0	14,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.

Remarks:

	s/ Gena L. Ashe, Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)